Latest filing published 16 Oct 2026 for UNITED THERAPEUTICS Corp, €1.1M. Read the official filing
All filings by Paul A. Mahon on record concern UNITED THERAPEUTICS Corp, in the capacity of senior executive. Between 7 January 2016 and 15 October 2026, the trades on record add up to 202 filings.
The open-market record consists of 77 sales worth €35.4M, with no purchase. Besides market trades, the filings include 121 option exercises. 2026 to date brings no purchases and 75 sales.
The latest filing, published on 16 October 2026, reports an option exercise of €1.1M in UNITED THERAPEUTICS Corp. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 202 declarations